PT - JOURNAL ARTICLE AU - Wiedemann, Anna AU - Stochl, Jan AU - Russo, Debra AU - Patel, Ushma AU - Ashford, Polly-Anna AU - Ali, Naima AU - Jones, Peter B AU - Perez, Jesus TI - Clinical Presentation of Psychotic Experiences in Patients with Common Mental Disorders Attending the UK Primary Care Improving Access to Psychological Therapies (IAPT) Programme AID - 10.1101/2023.08.26.23294566 DP - 2023 Jan 01 TA - medRxiv PG - 2023.08.26.23294566 4099 - http://medrxiv.org/content/early/2023/08/28/2023.08.26.23294566.short 4100 - http://medrxiv.org/content/early/2023/08/28/2023.08.26.23294566.full AB - Background Improving Access to Psychological Therapies (IAPT) services address anxiety and depression in primary care, but psychotic disorders are typically excluded. Our previous research found that 1 in 4 patients report distressing psychotic experiences (PE) alongside common mental disorders, yet little is known about their clinical presentation and their impact on recovery.Methods We used the Community Assessment of Psychic Experiences - Positive Scale (CAPE-P15) to determine the clinical presentation of PE within IAPT settings. We identified different classes (sub- groups) based on the reported frequencies of PE within this population using latent class analysis.Results A total of 2,042 IAPT patients completed the CAPE-P15. The mean age was 39.8 (± 15.3) years. We identified five distinct classes of symptom profiles, findings that PE were common, especially self-referential and persecutory ideas. Prevalence and intensity increased across classes, extending to bizarre experiences and perceptual abnormalities (hallucinations) in the fifth and least common class. Perceptual abnormalities were a strong indicator of symptom severity, and patients reporting such experiences were the least likely to achieve recovery by the end of treatment.Limitations We collected data from IAPT services that included self-report questionnaires, which may have affected the validity of the reported experiences. We did not collect information on negative PE.Conclusions Patients seeking treatment for anxiety and depression in primary care commonly experience a wide range of positive PE. Self-referential and persecutory ideation emerged as prevalent experiences; perceptual abnormalities were infrequent. Providing information about prevalence and tailoring therapy may help reduce patient distress.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (Reference Number RP-PG-0616-20003). All research in the Department of Psychiatry, University of Cambridge, is supported in part by the NIHR ARC East of England and the Cambridge BRC. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funding body had no role in study design; collection, analysis, or interpretation of data; the writing of the report; or decision to submit the paper.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Our study was approved by and registered with the official NHS Quality Improvement Programmes of all participating NHS Foundation Trusts and confirmed as such by the UK Health Research Authority (https://www.hra.nhs.uk/). We followed the UK Anonymisation Standard for Publishing Health and Social Care Data (https://digital.nhs.uk/) guidelines for data analysis.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.